ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

Balance Sheet Alibaba Health Information Technology Limited

Equities

241 BMG0171K1018

Drug Retailers

Market Closed - Hong Kong S.E. Other stock markets 08:08:06 14/01/2026 GMT			5-day change	1st Jan Change
7.780 ^HKD	+18.96%		+40.69%	+54.06%

01:55pm	Boring No More
09:14am	Alibaba Health Shares Climb Amid Optimism Over AI Use in Healthcare	DJ

b2eee2a2827.Kjf17ljwSQ-HAVwK_YlOUqQAuGJr4X0r1LT0cl7z-z8.R1ShsQq2eV30TQ1GxKQgOsN37Cc9hDdBs-SjNj-fgglIRLmCGbEtW-FVDQ

Published financial data: ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	15.52B	20.58B	26.76B	27.03B	30.6B
Total Revenues	15.52B	20.58B	26.76B	27.03B	30.6B
Cost of Goods Sold, Total	11.92B	16.47B	21.06B	21.13B	23.17B
Gross Profit	3.6B	4.11B	5.7B	5.9B	7.43B
Selling General & Admin Expenses, Total	3.14B	4.47B	5.06B	4.55B	5.23B
R&D Expenses	424M	729M	678M	705M	720M
Other Operating Expenses	7.91M	3.95M	19.72M	5.33M	24.91M
Other Operating Expenses, Total	3.57B	5.2B	5.75B	5.26B	5.98B
Operating Income	36.25M	-1.1B	-51.5M	635M	1.45B
Interest Expense, Total	-2.45M	-3.82M	-5.83M	-5.97M	-2.61M
Interest And Investment Income	167M	214M	332M	509M	489M
Net Interest Expenses	164M	210M	326M	503M	486M
Income (Loss) On Equity Invest.	-38.41M	-45.62M	11.38M	-5.93M	-64.66M
Currency Exchange Gains (Loss)	32.42M	39.7M	72.06M	7.09M	-37.14M
Other Non Operating Income (Expenses)	69.15M	103M	99.17M	92.17M	121M
EBT, Excl. Unusual Items	264M	-789M	457M	1.23B	1.96B
Merger & Related Restructuring Charges	-	-2.63M	-	-	-
Gain (Loss) On Sale Of Investments	66.88M	542M	115M	-283M	-399M
Gain (Loss) On Sale Of Assets	70.61M	142K	-1.24M	526K	619K
Other Unusual Items	-	-2.78M	-19.51M	-8.46M	-
EBT, Incl. Unusual Items	401M	-253M	551M	939M	1.56B
Income Tax Expense	58.54M	13.43M	16.73M	56.26M	128M
Earnings From Continuing Operations	343M	-266M	534M	883M	1.43B
Net Income to Company	343M	-266M	534M	883M	1.43B
Minority Interest	5.91M	386K	-856K	341K	413K
Net Income - (IS)	349M	-266M	533M	883M	1.43B
Net Income to Common Incl Extra Items	349M	-266M	533M	883M	1.43B
Net Income to Common Excl. Extra Items	349M	-266M	533M	883M	1.43B
Per Share Items
Net EPS - Basic	0.03	-0.02	0.04	0.06	0.09
Basic EPS - Continuing Operations	0.03	-0.02	0.04	0.06	0.09
Basic Weighted Average Shares Outstanding	13.25B	13.48B	13.5B	14.04B	16.07B
Net EPS - Diluted	0.03	-0.02	0.04	0.06	0.09
Diluted EPS - Continuing Operations	0.03	-0.02	0.04	0.06	0.09
Diluted Weighted Average Shares Outstanding	13.33B	13.48B	13.54B	14.09B	16.14B
Normalized Basic EPS	0.01	-0.04	0.02	0.05	0.08
Normalized Diluted EPS	0.01	-0.04	0.02	0.05	0.08
American Depositary Receipts Ratio (ADR)	20	20	20	20	20
Supplemental Items
EBITDA	50.92M	-1.07B	-24.48M	659M	1.49B
EBITA	38.27M	-1.08B	-33.99M	652M	1.47B
EBIT	36.25M	-1.1B	-51.5M	635M	1.45B
EBITDAR	51.24M	-1.07B	-23.35M	660M	1.49B
Effective Tax Rate - (Ratio)	14.59	-5.32	3.04	5.99	8.2
Current Domestic Taxes	39.32M	34.52M	31.2M	84.64M	139M
Total Current Taxes	39.32M	34.52M	31.2M	84.64M	139M
Deferred Domestic Taxes	19.22M	-21.1M	-14.46M	-	-
Total Deferred Taxes	19.22M	-21.1M	-14.46M	-28.38M	-10.58M
Normalized Net Income	171M	-493M	285M	770M	1.22B
Interest on Long-Term Debt	2.45M	3.82M	5.83M	5.97M	2.61M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.22B	1.98B	1.77B	1.78B	2.26B
General and Administrative Expenses	294M	392M	379M	360M	407M
Research And Development Expense From Footnotes	424M	729M	678M	705M	720M
Net Rental Expense, Total	317K	878K	1.13M	1.65M	2.13M
Imputed Operating Lease Interest Expense	116K	310K	493K	986K	756K
Imputed Operating Lease Depreciation	201K	568K	633K	666K	1.38M
Stock-Based Comp., COGS (Total)	16.51M	16.13M	15.41M	12.83M	9.8M
Stock-Based Comp., R&D Exp. (Total)	139M	139M	98.7M	79.78M	90.28M
Stock-Based Comp., S&M Exp. (Total)	121M	121M	89.32M	65.7M	18.8M
Stock-Based Comp., G&A Exp. (Total)	90.32M	98.53M	69.4M	76.04M	76.65M
Stock-Based Comp., SG&A Exp. (Total)	30.13M	33.73M	36.06M	31.71M	29M
Total Stock-Based Compensation	397M	408M	309M	266M	225M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	11.64B	10.55B	10.92B	9.55B	2.22B
Short Term Investments	-	-	-	-	5.62B
Trading Asset Securities, Total	-	-	-	-	264M
Total Cash And Short Term Investments	11.64B	10.55B	10.92B	9.55B	8.1B
Accounts Receivable, Total	314M	516M	579M	785M	1.05B
Other Receivables	459M	558M	701M	1.13B	1.02B
Total Receivables	773M	1.07B	1.28B	1.91B	2.07B
Inventory	1.47B	1.55B	2.1B	1.4B	1.42B
Prepaid Expenses	310M	330M	465M	370M	384M
Restricted Cash	11.02M	63.12M	150M	278M	303M
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	14.2B	13.57B	14.91B	13.51B	12.28B
Gross Property Plant And Equipment	134M	245M	151M	175M	144M
Accumulated Depreciation	-81.26M	-79.97M	-82.31M	-71.22M	-74.46M
Net Property Plant And Equipment	52.29M	165M	68.55M	104M	69.72M
Long-term Investments	3.41B	4.3B	4.59B	4.9B	7.6B
Goodwill	54.58M	811M	811M	811M	811M
Other Intangibles, Total	2.94M	326M	309M	292M	275M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	17.39M	33.83M	54.87M	50.82M
Other Long-Term Assets, Total	16.1M	20.29M	20.02M	31.57M	93.48M
Total Assets	17.74B	19.2B	20.75B	19.71B	21.18B
Liabilities
Accounts Payable, Total	2.55B	3.53B	3.71B	3.35B	2.85B
Accrued Expenses, Total	106M	170M	176M	92.71M	215M
Short-term Borrowings	-	-	-	-	-
Current Portion of Leases	20.33M	50.66M	37.44M	34.19M	10.58M
Current Income Taxes Payable	50.28M	40.83M	63.4M	88.87M	136M
Unearned Revenue Current, Total	191M	261M	495M	555M	695M
Other Current Liabilities	482M	772M	951M	904M	833M
Total Current Liabilities	3.4B	4.82B	5.44B	5.03B	4.74B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	17.41M	84.76M	40.36M	47.98M	24.94M
Deferred Tax Liability Non Current	39.32M	116M	122M	114M	98.15M
Other Non Current Liabilities	-	106M	-	-	-
Total Liabilities	3.46B	5.13B	5.6B	5.19B	4.87B
Common Stock, Total	119M	119M	119M	143M	143M
Additional Paid In Capital	43.28B	43.5B	43.73B	51.37B	51.52B
Retained Earnings	-986M	-1.31B	-842M	-11.97M	1.32B
Treasury Stock	-22.26M	-23.52M	-70.48M	-102M	-52.6M
Comprehensive Income and Other	-28.09B	-28.19B	-27.77B	-36.86B	-36.62B
Total Common Equity	14.3B	14.1B	15.17B	14.54B	16.31B
Minority Interest	-20.35M	-26.19M	-26.37M	-26.61M	981K
Total Equity	14.28B	14.07B	15.15B	14.52B	16.31B
Total Liabilities And Equity	17.74B	19.2B	20.75B	19.71B	21.18B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	13.45B	13.49B	13.5B	14.58B	16.08B
ECS Total Common Shares Outstanding	13.45B	13.49B	13.5B	14.58B	16.08B
Book Value / Share	1.06	1.05	1.12	1	1.01
Tangible Book Value	14.24B	12.96B	14.05B	13.44B	15.23B
Tangible Book Value Per Share	1.06	0.96	1.04	0.92	0.95
Total Debt	37.74M	135M	77.8M	82.17M	35.52M
Net Debt	-11.6B	-10.41B	-10.84B	-9.47B	-8.06B
Debt Equivalent Oper. Leases	2.54M	7.02M	9.01M	13.22M	17.05M
Minority Interest, Total (Incl. Fin. Div)	-20.35M	-26.19M	-26.37M	-26.61M	981K
Equity Method Investments, Total	2.27B	2.5B	2.59B	2.54B	1.73B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	-	1.55B	2.1B	1.4B	1.42B
Machinery, Total	78.58M	74.8M	71.45M	81.91M	86.43M
Full Time Employees	1.03K	1.85K	1.56K	1.44K	1.36K
Accumulated Allowance for Doubtful Accounts (Supple)	26.59M	26.72M	28.54M	33.69M	36.26M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	349M	-266M	533M	883M	1.43B
Depreciation & Amortization - CF	37.61M	48.67M	46.21M	36.72M	40.77M
Amortization of Goodwill and Intangible Assets - (CF)	2.01M	11.9M	17.51M	16.96M	16.84M
Depreciation & Amortization, Total	39.63M	60.58M	63.72M	53.68M	57.6M
(Gain) Loss From Sale Of Asset	-70.53M	-142K	1.24M	-526K	-619K
(Gain) Loss on Sale of Investments - (CF)	-65.74M	-542M	-112M	283M	399M
Provision for Credit Losses	-	-	-	-2.5M	-
(Income) Loss On Equity Investments - (CF)	38.41M	45.62M	-11.38M	5.93M	64.66M
Stock-Based Compensation (CF)	397M	408M	309M	266M	225M
Provision and Write-off of Bad Debts	-320K	132K	1.82M	5.14M	6.21M
Other Operating Activities, Total	-14.16M	63.63M	38.36M	-77.36M	-221M
Change In Accounts Receivable	7.44M	-202M	-64.63M	-211M	-274M
Change In Inventories	-284M	-129M	-712M	614M	-108M
Change In Accounts Payable	716M	960M	187M	-363M	-498M
Change in Unearned Revenues	19.26M	70.1M	234M	59.62M	140M
Change in Other Net Operating Assets	-122M	-44.39M	-213M	-436M	171M
Cash from Operations	1.01B	424M	256M	1.08B	1.4B
Capital Expenditure	-17.08M	-14.93M	-5.61M	-22.77M	-18.89M
Sale of Property, Plant, and Equipment	822K	1.86M	413K	748K	5.97M
Cash Acquisitions	-	-816M	-77.33M	-131M	-
Divestitures	-10.61M	-	-	-	-
Sale (Purchase) of Intangible assets	-481K	-185K	-308K	-6K	-10K
Investment in Marketable and Equity Securities, Total	-4.72B	2.8B	-512M	-4.86B	-2.94B
Net (Increase) Decrease in Loans Originated / Sold - Investing	25M	13.9M	-	13.39M	10.63M
Other Investing Activities, Total	-235M	-112M	62.88M	116M	349M
Cash from Investing	-4.96B	1.87B	-532M	-4.88B	-2.6B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-31.62M	-47.01M	-42.59M	-39.93M	-38.09M
Total Debt Repaid	-31.62M	-47.01M	-42.59M	-39.93M	-38.09M
Issuance of Common Stock	8.99B	9.69M	12.89M	878K	4.59M
Repurchase of Common Stock	-39.58M	-16.52M	-81.58M	-105M	-39.93M
Other Financing Activities, Total	-110K	-4.79M	-	-1.84B	921K
Cash from Financing	8.92B	-58.63M	-111M	-1.98B	-72.52M
Foreign Exchange Rate Adjustments	-313M	-149M	283M	36.78M	2.09M
Net Change in Cash	4.66B	2.09B	-105M	-5.75B	-1.27B
Supplemental Items
Cash Interest Paid	2.45M	3.82M	5.83M	5.97M	2.61M
Cash Income Tax Paid (Refund)	27.9M	45.34M	43.11M	40.61M	107M
Levered Free Cash Flow	695M	703M	-19.58M	319M	693M
Unlevered Free Cash Flow	697M	705M	-15.93M	322M	695M
Change In Net Working Capital	-255M	-936M	350M	371M	477M
Net Debt Issued / Repaid	-31.62M	-47.01M	-42.59M	-39.93M	-38.09M

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.18	-3.71	-0.16	1.96	4.44
Return on Total Capital	0.23	-4.8	-0.22	2.66	5.87
Return On Equity %	3.52	-1.88	3.66	5.95	9.29
Return on Common Equity	3.56	-1.87	3.64	5.95	9.28
Margin Analysis
Gross Profit Margin %	23.22	19.96	21.3	21.81	24.29
SG&A Margin	20.2	21.73	18.89	16.83	17.1
EBITDA Margin %	0.33	-5.22	-0.09	2.44	4.86
EBITA Margin %	0.25	-5.27	-0.13	2.41	4.81
EBIT Margin %	0.23	-5.33	-0.19	2.35	4.75
Income From Continuing Operations Margin %	2.21	-1.29	2	3.27	4.68
Net Income Margin %	2.25	-1.29	1.99	3.27	4.68
Net Avail. For Common Margin %	2.25	-1.29	1.99	3.27	4.68
Normalized Net Income Margin	1.1	-2.4	1.06	2.85	4
Levered Free Cash Flow Margin	4.48	3.41	-0.07	1.18	2.27
Unlevered Free Cash Flow Margin	4.49	3.43	-0.06	1.19	2.27
Asset Turnover
Asset Turnover	1.21	1.11	1.34	1.34	1.5
Fixed Assets Turnover	229.53	189.31	229.08	313.87	352.95
Receivables Turnover (Average Receivables)	48.64	49.61	48.89	39.63	33.3
Inventory Turnover (Average Inventory)	8.87	10.91	11.53	12.07	16.46
Short Term Liquidity
Current Ratio	4.18	2.81	2.74	2.69	2.59
Quick Ratio	3.65	2.41	2.24	2.28	2.15
Operating Cash Flow to Current Liabilities	0.3	0.09	0.05	0.21	0.29
Days Sales Outstanding (Average Receivables)	7.5	7.36	7.47	9.24	10.96
Days Outstanding Inventory (Average Inventory)	41.14	33.45	31.65	30.33	22.18
Average Days Payable Outstanding	66.25	67.04	61.15	63.28	48.83
Cash Conversion Cycle (Average Days)	-17.61	-26.23	-22.04	-23.72	-15.7
Long Term Solvency
Total Debt/Equity	0.26	0.96	0.51	0.57	0.22
Total Debt / Total Capital	0.26	0.95	0.51	0.56	0.22
LT Debt/Equity	0.12	0.6	0.27	0.33	0.15
Long-Term Debt / Total Capital	0.12	0.6	0.26	0.33	0.15
Total Liabilities / Total Assets	19.49	26.71	26.99	26.33	22.97
EBIT / Interest Expense	14.8	-287.24	-8.83	106.36	557.15
EBITDA / Interest Expense	30.98	-271.36	2.09	115.35	579.23
(EBITDA - Capex) / Interest Expense	24.01	-275.27	1.13	111.54	571.99
Total Debt / EBITDA	0.5	-0.13	6.37	0.12	0.02
Net Debt / EBITDA	-152.86	10.06	-887.38	-13.76	-5.34
Total Debt / (EBITDA - Capex)	0.64	-0.13	11.78	0.12	0.02
Net Debt / (EBITDA - Capex)	-197.26	9.92	-1.64K	-14.23	-5.4
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	61.71	32.6	30.06	0.98	13.22
Gross Profit, 1 Yr. Growth %	61.85	13.57	38.79	3.4	26.07
EBITDA, 1 Yr. Growth %	-196.02	-2.16K	-97.73	-2.79K	125.54
EBITA, 1 Yr. Growth %	-158.03	-2.85K	-96.87	-2.02K	125.6
EBIT, 1 Yr. Growth %	-153.77	-3.02K	-95.31	-1.33K	128.97
Earnings From Cont. Operations, 1 Yr. Growth %	-2.28K	-177.61	-300.9	64.61	62.15
Net Income, 1 Yr. Growth %	-5.39K	-176.18	-300.86	64.93	62.14
Normalized Net Income, 1 Yr. Growth %	-1.63K	-387.43	-157.55	170.33	59.14
Diluted EPS Before Extra, 1 Yr. Growth %	-4.47K	-175.19	-300	58.33	41.63
Accounts Receivable, 1 Yr. Growth %	-3.37	64.53	12.17	35.65	34.06
Inventory, 1 Yr. Growth %	20.65	5.55	35.62	-33.42	1.11
Net Property, Plant and Equip., 1 Yr. Growth %	-36.95	215.76	-58.48	51.23	-32.75
Total Assets, 1 Yr. Growth %	125.4	8.25	8.05	-5.02	7.48
Tangible Book Value, 1 Yr. Growth %	173.4	-9.01	8.43	-4.36	13.28
Common Equity, 1 Yr. Growth %	171.43	-1.42	7.63	-4.15	12.16
Cash From Operations, 1 Yr. Growth %	72.96	-57.96	-39.75	322.32	29.19
Capital Expenditures, 1 Yr. Growth %	125.68	-12.57	-62.41	305.81	-17.04
Levered Free Cash Flow, 1 Yr. Growth %	23.13	0.92	-102.79	-1.73K	117.48
Unlevered Free Cash Flow, 1 Yr. Growth %	20.48	1.04	-102.27	-2.12K	115.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	74.51	46.43	31.32	14.6	6.93
Gross Profit, 2 Yr. CAGR %	64.58	35.85	25.54	19.8	14.17
EBITDA, 2 Yr. CAGR %	-26.47	350.02	-31.48	-21.78	679.1
EBITA, 2 Yr. CAGR %	-37.57	305.42	-7.22	-22.55	557.72
EBIT, 2 Yr. CAGR %	-39.23	303.15	17.24	-23.98	431.26
Earnings From Cont. Operations, 2 Yr. CAGR %	93.24	311.62	24.86	82.23	63.37
Net Income, 2 Yr. CAGR %	106.25	534.99	23.7	82.4	63.53
Normalized Net Income, 2 Yr. CAGR %	90.58	563.59	28.84	24.73	107.41
Diluted EPS Before Extra, 2 Yr. CAGR %	88.01	472.99	22.63	78.41	49.75
Accounts Receivable, 2 Yr. CAGR %	-7.36	26.09	35.85	23.35	34.85
Inventory, 2 Yr. CAGR %	57	12.85	19.65	-4.98	-17.95
Net Property, Plant and Equip., 2 Yr. CAGR %	142.58	41.1	14.5	-20.76	0.85
Total Assets, 2 Yr. CAGR %	72.21	56.2	8.15	1.3	1.03
Tangible Book Value, 2 Yr. CAGR %	126.87	57.73	-0.67	1.83	4.09
Common Equity, 2 Yr. CAGR %	126.23	63.57	3	1.57	3.68
Cash From Operations, 2 Yr. CAGR %	59.58	-14.73	-49.67	59.52	133.58
Capital Expenditures, 2 Yr. CAGR %	67.29	40.46	-42.67	23.51	83.48
Levered Free Cash Flow, 2 Yr. CAGR %	28.94	11.53	-83.23	-32.56	495.09
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.47	10.39	-84.89	-32.28	560.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	85.21	59.24	40.76	20.31	14.14
Gross Profit, 3 Yr. CAGR %	76.93	45.63	36.82	17.68	21.85
EBITDA, 3 Yr. CAGR %	-27.86	125.08	-22.72	132.91	11.34
EBITA, 3 Yr. CAGR %	-35.13	122.67	-19.82	154.62	10.61
EBIT, 3 Yr. CAGR %	-36.29	123.49	-8.59	156.84	9.79
Earnings From Cont. Operations, 3 Yr. CAGR %	46.48	42.57	224.08	37.1	75.28
Net Income, 3 Yr. CAGR %	48.26	47.98	332.66	36.34	75.38
Normalized Net Income, 3 Yr. CAGR %	47.2	118.88	194.07	64.94	35.28
Diluted EPS Before Extra, 3 Yr. CAGR %	31.04	38.52	303.44	33.76	65.19
Accounts Receivable, 3 Yr. CAGR %	50.84	12.19	21.27	35.78	26.82
Inventory, 3 Yr. CAGR %	49.19	37.54	19.98	-1.59	-2.99
Net Property, Plant and Equip., 3 Yr. CAGR %	102.75	164.86	-6.15	25.63	-24.98
Total Assets, 3 Yr. CAGR %	78.65	47.51	38.14	3.57	3.32
Tangible Book Value, 3 Yr. CAGR %	77.18	67.31	39.2	-1.92	5.51
Common Equity, 3 Yr. CAGR %	76.97	71.51	42.27	0.56	4.98
Cash From Operations, 3 Yr. CAGR %	143.09	2.3	-24.05	2.27	48.69
Capital Expenditures, 3 Yr. CAGR %	43.9	34.75	-9.48	10.07	8.16
Levered Free Cash Flow, 3 Yr. CAGR %	67.19	18.87	-67.4	-22.92	-0.37
Unlevered Free Cash Flow, 3 Yr. CAGR %	69.75	17.39	-69.8	-22.68	-0.4
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	207.34	112.48	61.41	39.61	26.1
Gross Profit, 5 Yr. CAGR %	148.54	85.46	54.37	34.69	27.27
EBITDA, 5 Yr. CAGR %	-24.87	40.27	-29	47.55	94.75
EBITA, 5 Yr. CAGR %	-29.27	39.88	-24.67	46.03	86.06
EBIT, 5 Yr. CAGR %	-30.03	40.19	-18.15	45.26	84.81
Earnings From Cont. Operations, 5 Yr. CAGR %	11.49	4.97	37.42	57.28	146.62
Net Income, 5 Yr. CAGR %	12.71	5.04	37.9	60.89	193.42
Normalized Net Income, 5 Yr. CAGR %	8.4	30.35	39.68	74.91	155.74
Diluted EPS Before Extra, 5 Yr. CAGR %	2.25	-4.95	27.61	53.27	171.68
Accounts Receivable, 5 Yr. CAGR %	394.56	68.05	44.66	16.53	26.53
Inventory, 5 Yr. CAGR %	-	59.22	36.59	18.63	3.06
Net Property, Plant and Equip., 5 Yr. CAGR %	51.53	100.74	61.32	63.45	-3.41
Total Assets, 5 Yr. CAGR %	67.43	62.79	46.16	26.93	21.89
Tangible Book Value, 5 Yr. CAGR %	63.44	62.08	40.56	37.17	23.92
Common Equity, 5 Yr. CAGR %	63.57	64.29	42.52	39.08	25.36
Cash From Operations, 5 Yr. CAGR %	53.83	13.4	29.48	22.19	19.04
Capital Expenditures, 5 Yr. CAGR %	14.35	47.48	-0.42	30.13	20.08
Levered Free Cash Flow, 5 Yr. CAGR %	78.53	59.47	-33.35	-5.29	4.18
Unlevered Free Cash Flow, 5 Yr. CAGR %	78.61	61.67	-35.48	-5.84	3.74